Bangkok Dusit Medical Services PCL (BDMS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Bangkok Dusit Medical Services PCL (BDMS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10141
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:タイ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bangkok Dusit Medical Services PCL (BDMS) is a private hospital operator that offers healthcare services. It provides medical services and patient services in various therapeutic areas through its medical centers. BDMS operates its business through a network of hospitals namely, Bangkok Hospital Group, Samitivej Hospital Group, Phyathai Hospital Group, Paolo Hospital Group, Royal Hospital Group and BNH Hospital. It has research collaborations with foreign medical institutions such as Department of Orthopaedic Surgery at Stanford University, University of Texas MD Anderson Cancer Center, Oregon Health & Science University; and Nagoya University, Japan. BDMS is headquartered in Bangkok, Thailand.

Bangkok Dusit Medical Services PCL (BDMS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bangkok Dusit Medical Services PCL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bangkok Dusit Medical Services PCL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bangkok Dusit Medical Services PCL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bangkok Dusit Medical Services PCL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Bangkok Dusit Medical Services PCL, Pharmaceuticals & Healthcare, Deal Details 9
Equity Offering 9
Bangkok Dusit Medical Services Announces Public Offering Of Shares For US$2.3 Million 9
Bangkok Dusit Medical Services Announces Private Placement Of Shares For US$2.3 Million 10
Debt Offering 11
Bangkok Dusit Medical Services to Raise USD311 Million in Public Offering of Bonds 11
Acquisition 12
Bangkok Phuket International Hospital Acquires Phuket International Hospital for USD126 Million 12
Bangkok Dusit Medical Services Acquires Ratanavej Hospital for USD18.4 Million 13
Bangkok Dusit Commences Tender Offer To Acquire Remaining 55.04% Stake In Krungdhon Hospital For US$15 Million 14
Bangkok Dusit Medical Services Acquires Additional 6.05% Stake In Bumrungrad Hospital For US$73 Million 15
Bangkok Dusit Medical Services PCL – Key Competitors 16
Bangkok Dusit Medical Services PCL – Key Employees 17
Bangkok Dusit Medical Services PCL – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 20
Corporate Communications 20
Nov 29, 2017: Bangkok Dusit Medical Services: Resignation of Independent Director 20
Nov 23, 2017: Resignation of an Independent Director 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Bangkok Dusit Medical Services PCL, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Bangkok Dusit Medical Services PCL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Bangkok Dusit Medical Services PCL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bangkok Dusit Medical Services PCL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bangkok Dusit Medical Services PCL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bangkok Dusit Medical Services PCL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Bangkok Dusit Medical Services Announces Public Offering Of Shares For US$2.3 Million 9
Bangkok Dusit Medical Services Announces Private Placement Of Shares For US$2.3 Million 10
Bangkok Dusit Medical Services to Raise USD311 Million in Public Offering of Bonds 11
Bangkok Phuket International Hospital Acquires Phuket International Hospital for USD126 Million 12
Bangkok Dusit Medical Services Acquires Ratanavej Hospital for USD18.4 Million 13
Bangkok Dusit Commences Tender Offer To Acquire Remaining 55.04% Stake In Krungdhon Hospital For US$15 Million 14
Bangkok Dusit Medical Services Acquires Additional 6.05% Stake In Bumrungrad Hospital For US$73 Million 15
Bangkok Dusit Medical Services PCL, Key Competitors 16
Bangkok Dusit Medical Services PCL, Key Employees 17
Bangkok Dusit Medical Services PCL, Subsidiaries 18

List of Figures
Bangkok Dusit Medical Services PCL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bangkok Dusit Medical Services PCL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bangkok Dusit Medical Services PCL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bangkok Dusit Medical Services PCL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bangkok Dusit Medical Services PCL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Bangkok Dusit Medical Services PCL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Bangkok Dusit Medical Services PCL (BDMS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Highland Gold Mining Limited:企業の戦略・SWOT・財務分析
    Highland Gold Mining Limited - Strategy, SWOT and Corporate Finance Report Summary Highland Gold Mining Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • McCain Foods Ltd:戦略・SWOT・企業財務分析
    McCain Foods Ltd - Strategy, SWOT and Corporate Finance Report Summary McCain Foods Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Intersect ENT Inc (XENT):企業の財務・戦略的SWOT分析
    Summary Intersect ENT Inc (Intersect), formerly Sinexus Inc is a medical device company that offers chronic sinusitis solutions. The company offers steroid releasing implants and mini steroid implants. It provides surgical solutions for patients, disease recurrence with recurrent symptoms. Intersect …
  • Discovery Communications, Inc.
    Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Panasonic Homes Co., Ltd.:企業の戦略的SWOT分析
    Panasonic Homes Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Sam’s West Inc:企業の戦略的SWOT分析
    Sam's West Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Altimmune Inc-製薬・医療分野:企業M&A・提携分析
    Summary Altimmune Inc (Altimmune), formerly Vaxin Inc is a biotechnology company that develops vaccines and other biological products. The company's products include novel vaccine delivery platforms, immunotherapeutic products, intranasally administered recombinant influenza vaccine, traditional inf …
  • The Dai-ichi Life Insurance Co Ltd:戦略・SWOT・企業財務分析
    The Dai-ichi Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Dai-ichi Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Teradata Corp (TDC):企業の財務・戦略的SWOT分析
    Teradata Corp (TDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Clean Energy Fuels Corp (CLNE):石油・ガス:M&Aディール及び事業提携情報
    Summary Clean Energy Fuels Corp (Clean Energy) is an oil and gas company that offers natural gas fuel transportation services. The company’s products fuels, liquefied natural gas, compressed natural gas, renewable natural gas, and bulk fuels. It also provides storage systems, compressors, dispensers …
  • City Holding Co (CHCO):企業の財務・戦略的SWOT分析
    City Holding Co (CHCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Info Edge (India) Limited:企業のM&A・事業提携・投資動向
    Info Edge (India) Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Info Edge (India) Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Teijin Pharma Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Teijin Pharma Ltd (Teijin Pharma), a subsidiary of Teijin Ltd develops, manufactures and markets pharmaceutical and home healthcare products. The company offers a range of pharmaceutical products for the treatment of bone and joint diseases, respiratory diseases and cardiovascular and metabo …
  • NAPEC Inc (NPC):企業の財務・戦略的SWOT分析
    NAPEC Inc (NPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Wageningen University-製薬・医療分野:企業M&A・提携分析
    Summary Wageningen University (WU), a subsidiary of Wageningen University and Research Centre, is an education and research institution. The university offers bachelors’, masters’ and PhD programs. It specializes in healthy food and living environment domain. WU offers various courses in bachelor of …
  • Egalet Corp (EGLT):医療機器:M&Aディール及び事業提携情報
    Summary Egalet Corp (Egalet) is a specialty pharmaceutical company that develops, manufactures and commercializes novel treatments for pain and other conditions. Its product portfolio includes OXAYDO (oxycodone HCl, USP) tablets CII for the management of acute and chronic moderate to severe pain; SP …
  • Helix BioPharma Corp (HBP)-製薬・医療分野:企業M&A・提携分析
    Summary Helix BioPharma Corp (Helix) is a biopharmaceutical company with a focus in the field of cancer therapy. The company develops drug candidates for the prevention and treatment of cancer. It develops drugs based on its proprietary technologies. DOS47, the company's proprietary broad anti-cance …
  • W.H. Brakspear & Sons Limited:企業の戦略・SWOT・財務情報
    W.H. Brakspear & Sons Limited - Strategy, SWOT and Corporate Finance Report Summary W.H. Brakspear & Sons Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • F. Hoffmann-La Roche Ltd:戦略・SWOT・企業財務分析
    F. Hoffmann-La Roche Ltd - Strategy, SWOT and Corporate Finance Report Summary F. Hoffmann-La Roche Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Angelini Group:製薬・医療:M&Aディール及び事業提携情報
    Summary Angelini Group (Angelini) manufactures, markets and distributes pharmaceutical and healthcare products. The company operates in prescription and over-the-counter (OTC) pharmaceutical sectors with focus on pain and inflammation disorders, infection control and infectious diseases and central …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆